See more : Kirloskar Ferrous Industries Limited (KIRLFER.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Sotera Health Company (SHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sotera Health Company, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- Navitas Semiconductor Corporation (NVTSW) Income Statement Analysis – Financial Results
- Jiangsu Guotai International Group Co., Ltd. (002091.SZ) Income Statement Analysis – Financial Results
- Çelebi Hava Servisi A.S. (CLEBI.IS) Income Statement Analysis – Financial Results
- Bank of China Limited (BACHY) Income Statement Analysis – Financial Results
- Deson Development International Holdings Limited (0262.HK) Income Statement Analysis – Financial Results
Sotera Health Company (SHC)
About Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.05B | 1.00B | 931.48M | 818.16M | 778.33M | 746.15M |
| Cost of Revenue | 472.13M | 446.68M | 412.81M | 374.59M | 382.90M | 388.90M |
| Gross Profit | 577.16M | 557.00M | 518.67M | 443.57M | 395.43M | 357.25M |
| Gross Profit Ratio | 55.00% | 55.50% | 55.68% | 54.22% | 50.81% | 47.88% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 133.36M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 236.67M | 245.71M | 198.16M | 178.53M | 147.48M | 133.36M |
| Other Expenses | 63.80M | 62.94M | 63.78M | 59.03M | 58.56M | 3.87M |
| Operating Expenses | 300.47M | 308.65M | 261.94M | 237.55M | 206.04M | 191.34M |
| Cost & Expenses | 772.60M | 755.34M | 674.75M | 612.14M | 588.94M | 580.24M |
| Interest Income | 0.00 | 80.14M | 74.19M | 215.26M | 157.73M | 0.00 |
| Interest Expense | 142.88M | 80.14M | 74.19M | 215.26M | 157.73M | 143.33M |
| Depreciation & Amortization | 160.34M | 147.75M | 153.15M | 145.51M | 148.77M | 148.15M |
| EBITDA | 420.20M | -2.99M | 404.25M | 319.96M | 305.25M | 316.60M |
| EBITDA Ratio | 40.05% | 31.66% | 36.04% | 33.55% | 44.11% | 42.43% |
| Operating Income | 276.69M | 248.35M | 256.73M | 206.02M | 183.60M | 80.85M |
| Operating Income Ratio | 26.37% | 24.74% | 27.56% | 25.18% | 23.59% | 10.84% |
| Total Other Income/Expenses | -170.67M | -491.46M | -81.02M | -244.88M | -184.51M | -56.63M |
| Income Before Tax | 106.03M | -243.11M | 175.72M | -38.86M | -916.00K | 24.22M |
| Income Before Tax Ratio | 10.10% | -24.22% | 18.86% | -4.75% | -0.12% | 3.25% |
| Income Tax Expense | 54.65M | -9.54M | 58.60M | -1.37M | 19.51M | 30.10M |
| Net Income | 51.38M | -233.57M | 116.88M | -37.49M | -20.43M | -5.87M |
| Net Income Ratio | 4.90% | -23.27% | 12.55% | -4.58% | -2.62% | -0.79% |
| EPS | 0.18 | -0.83 | 0.41 | -0.13 | -0.07 | -0.02 |
| EPS Diluted | 0.18 | -0.83 | 0.41 | -0.13 | -0.07 | -0.02 |
| Weighted Avg Shares Out | 281.01M | 280.10M | 279.23M | 283.25M | 284.42M | 246.15M |
| Weighted Avg Shares Out (Dil) | 283.22M | 280.10M | 279.38M | 283.25M | 284.42M | 246.15M |
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sotera Health Company and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for...
ONGOING SHAREHOLDER INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sotera Health Company and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company ("Sotera" or "the Company") (NASDAQ: SHC)...
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sotera Health Company and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company ("Sotera" or "the Company") (NASDAQ: SHC)...
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sotera Health Company and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for...
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sotera Health Company and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sotera Health Company - SHC
NEW YORK , March 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating whether the Board of Directors of Sotera Health Company (NASDAQ: SHC) ("Sotera") potentially breached their fiduciary duties to shareholders. Such investors are advised to contact Danielle Peyton at...
Sotera Health Company (SHC) Q4 2023 Earnings Call Transcript
Sotera Health Company (SHC) Q4 2023 Earnings Call Transcript
Sotera Health Announces Pricing of Secondary Offering
CLEVELAND, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the pricing of its secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share, at a price to...
Sotera Health Announces Secondary Offering of Common Stock
CLEVELAND, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share. All 25,000,000 shares are being offered...
Sotera Health Company (SHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Sotera Health Company (SHC) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the...
Source: https://incomestatements.info
Category: Stock Reports